SCHEMBL3856098

SCHEMBL3856098

CCC(CC)(c1ccc(CCC(=O)C(C)(C)C)c(C(C)C)c1)c1cc2cc(C(=O)N(C)CC(=O)O)ccc2o1

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
VDR P11473 2/20 0.35
PPARD Q03181 3/20 0.34
ADAM17 P78536 1/20 0.31
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3852110 0.88 VDR (0.37) VDRPPARDRAB9A
SCHEMBL3855835 0.85 VDR (0.50) VDRPPARD
SCHEMBL13714180 0.79 VDR (0.52) VDR
SCHEMBL13713993 0.78 VDR (0.50) VDRPPARD
SCHEMBL13714020 0.77 VDR (0.59) VDR
SCHEMBL13714045 0.74 VDR (0.51) VDRPPARD
SCHEMBL13713954 0.73 VDR (0.60) VDR
SCHEMBL3851531 0.73 VDR (0.60) VDR
SCHEMBL3855199 0.72 VDR (0.47) VDR
SCHEMBL13713992 0.70 VDR (0.42) VDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7579488-B2 Vitamin D receptor modulators ELI LILLY AND COMPANY (US) 2009-08-25 US disclosed
US-20070106095-A1 Vitamin d receptor modulators ELI LILLY AND COMPANY 2007-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070106095-A1 Vitamin d receptor modulators VDR, CYP2R1, CYP24A1 VDR 1/4885PPARD 19/4885ADAM17 1553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.